Wolfe Research Initiates Coverage on Spyre Therapeutics (NASDAQ:SYRE)
Wolfe Research assumed coverage on shares of Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) in a research report issued ...
Spyre Therapeutics initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Spyre Therapeutics (SYRE) with an Outperform rating and $27 price target The company is an early stage ...
Nasdaq2d
Commit To Buy Spyre Therapeutics At $12.50, Earn 13.5% Annualized Using Options
Investors considering a purchase of Spyre Therapeutics Inc (Symbol: SYRE) stock, but cautious about paying the going market price of $18.16/share, might benefit from considering selling puts among ...
Investing3d
Wolfe Research initiates Spyre stock with Outperform rating
On Tuesday, Wolfe Research began coverage on Spyre (NASDAQ:SYRE), assigning the biopharmaceutical company an Outperform rating. The firm’s analyst, Andy Chen, provided a positive outlook based ...
Investing3d
Wolfe Research initiates Spyre stock with Outperform rating
On Tuesday, Wolfe Research began coverage on Spyre (NASDAQ:SYRE), assigning the biopharmaceutical company an Outperform rating. The firm’s analyst, Andy Chen, provided a positive outlook based on ...
Tennessee seeks to make secret revenue sharing payments to college athletes
It's all about winning. Tennessee was one of the first states to push for NIL rights for athletes and this is an extension of that strategy.
Knoxville News Sentinel6d
Tennessee seeks to make secret revenue sharing payments to college athletes
UT athletes are already compensated through NIL, which is run by Spyre Sports Group. This is how, for instance, Nico Iamaleava was signed to play with the Vols and also signed a contract with ...